Amgen
Utility Patents
Last updated:
List of all Amgen patents 222 in total
| Status | Patent |
|---|---|
Grant | Utility: Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Injector and method of assembly Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: ST2 antigen binding proteins Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Low-viscosity antigen binding proteins and methods of making them Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: KRAS G12C inhibitors and methods of using the same Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Antibodies targeting CDH19 for melanoma Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Formulation for bispecific T-cell engagers (BiTEs) Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: KRAS G12C inhibitors and methods of using the same Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Heteroaryl-substituted triazoles as APJ receptor agonists Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: High concentration antibody formulations Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Synthesis of omecamtiv mecarbil Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Single-use auto-injector Filling date: 6 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Anti-Jagged1 antigen binding proteins Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Cycloalkyl substituted triazole compounds as agonists of the APJ receptor Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Drug cassette, autoinjector, and autoinjector system Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers Filling date: 6 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: Compounds that inhibit Mcl-1 protein Filling date: 6 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Drug delivery system with electromagnetic field generator Filling date: 6 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: KRAS G12C inhibitors and methods of using the same Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Vial sleeve assembly Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: System and method for detecting activation of a medical delivery device Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Dual receptor antagonistic antigen-binding proteins and uses thereof Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Imaging system for counting and sizing particles in fluid-filled vessels Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Methods of determining exposure to UV light Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Substituted oxazines as beta-secretase inhibitors Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Purification systems and methods Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Apelin polypeptides Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Combination of epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Anti-mesothelin binding proteins Filling date: 6 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Autoinjector apparatus Filling date: 6 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Method for determining whether a peptide comprises aspartate or isoaspartate Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Triazole phenyl compounds as agonists of the APJ receptor Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Bisamide sarcomere activating compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Methods for increasing mannose content of recombinant proteins Filling date: 6 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Growth differentiation factor 15 (GDF-15) constructs Filling date: 6 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Thiazine derivatives as .beta.-secretase inhibitors and methods of use Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers Filling date: 6 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: RNAi constructs for inhibiting ASGR1 expression and methods of use thereof Filling date: 6 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane Filling date: 6 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Solution phase method for preparing etelcalcetide Filling date: 6 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Antibody constructs for CD70 and CD3 Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Interleukin-2 muteins for the expansion of T-regulatory cells Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Injector and method of assembly Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Showing 100 to 150 of 222 patents.